OssDsign: Q3, Catalyst positively surprises, but still a difficult climate - Redeye

Redeye is encouraged by the strong sales development, boosted by Catalyst contributing to c60% of US sales. While its spine product certainly positively surprised us, we emphasise a continuously challenging climate for elective surgeries and restricted hospital access, likely to depress sales in the medium term. We adjust our fair value range downwards following the report.

Länk till analysen i sin helhet: https://www.redeye.se/research/865036/ossdsign-q3-catalyst-positively-surprises-but-still-a-difficult-climate?utm_source=finwire&utm_medium=RSS